An official website of the United States government
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Trial Status: active
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled
study in participants with colorectal cancer who have cancer cachexia.
Inclusion Criteria
Documented active diagnosis of colorectal cancer.
Cachexia defined by Fearon criteria of weight loss.
Signed informed consent.
Exclusion Criteria
Current active reversible causes of decreased food intake.
Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
Have cachexia caused by other reasons.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07033026.
